These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34624687)

  • 41. Phosphorylation of αB-crystallin supports reactive astrogliosis in demyelination.
    Kuipers HF; Yoon J; van Horssen J; Han MH; Bollyky PL; Palmer TD; Steinman L
    Proc Natl Acad Sci U S A; 2017 Feb; 114(9):E1745-E1754. PubMed ID: 28196893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oligodendrocyte-specific deletion of FGFR2 ameliorates MOG
    Kamali S; Rajendran R; Stadelmann C; Karnati S; Rajendran V; Giraldo-Velasquez M; Berghoff M
    Brain Pathol; 2021 Mar; 31(2):297-311. PubMed ID: 33103299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of FXR pathway does not alter glial cell function.
    Albrecht S; Fleck AK; Kirchberg I; Hucke S; Liebmann M; Klotz L; Kuhlmann T
    J Neuroinflammation; 2017 Mar; 14(1):66. PubMed ID: 28351411
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
    Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
    Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sephin1, which prolongs the integrated stress response, is a promising therapeutic for multiple sclerosis.
    Chen Y; Podojil JR; Kunjamma RB; Jones J; Weiner M; Lin W; Miller SD; Popko B
    Brain; 2019 Feb; 142(2):344-361. PubMed ID: 30657878
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting epidermal fatty acid binding protein for treatment of experimental autoimmune encephalomyelitis.
    Rao E; Singh P; Li Y; Zhang Y; Chi YI; Suttles J; Li B
    BMC Immunol; 2015 May; 16():28. PubMed ID: 25962726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis.
    Ribeiro R; Yu F; Wen J; Vana A; Zhang Y
    Neuroscience; 2013 Dec; 254():427-42. PubMed ID: 24036373
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination.
    Loda E; Balabanov R
    Rev Neurosci; 2012 Jan; 23(2):145-52. PubMed ID: 22499673
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of Fabp7 and Fabp5 on postnatal hippocampal neurogenesis in the mouse.
    Matsumata M; Sakayori N; Maekawa M; Owada Y; Yoshikawa T; Osumi N
    Stem Cells; 2012 Jul; 30(7):1532-43. PubMed ID: 22581784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Involvement of Src-suppressed C kinase substrate in experimental autoimmune encephalomyelitis: a link between release of astrocyte proinflammatory factor and oligodendrocyte apoptosis.
    Li X; Yan M; Hu L; Sun L; Zhang F; Ji H; Jiang J; Wang P; Liu H; Gao Y; Tao T; He X; Cheng C; Shen A
    J Neurosci Res; 2010 Jul; 88(9):1858-71. PubMed ID: 20155814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oligodendroglial fibroblast growth factor receptor 1 gene targeting protects mice from experimental autoimmune encephalomyelitis through ERK/AKT phosphorylation.
    Rajendran R; Giraldo-Velásquez M; Stadelmann C; Berghoff M
    Brain Pathol; 2018 Mar; 28(2):212-224. PubMed ID: 28117910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells.
    Xiao Y; Lai L; Chen H; Shi J; Zeng F; Li J; Feng H; Mao J; Zhang F; Wu N; Xu Y; Tan Z; Gong F; Zheng F
    Mol Immunol; 2018 Sep; 101():550-563. PubMed ID: 30173119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C
    J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis.
    Bagnoud M; Briner M; Remlinger J; Meli I; Schuetz S; Pistor M; Salmen A; Chan A; Hoepner R
    Cells; 2020 Sep; 9(10):. PubMed ID: 32977663
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Connexins in oligodendrocytes and astrocytes: Possible factors for demyelination in multiple sclerosis.
    Xia CY; Xu JK; Pan CH; Lian WW; Yan Y; Ma BZ; He J; Zhang WK
    Neurochem Int; 2020 Jun; 136():104731. PubMed ID: 32201280
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oligodendrocyte-specific ATF4 inactivation does not influence the development of EAE.
    Yue Y; Stanojlovic M; Lin Y; Karsenty G; Lin W
    J Neuroinflammation; 2019 Feb; 16(1):23. PubMed ID: 30709400
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [
    Hoehne A; James ML; Alam IS; Ronald JA; Schneider B; D'Souza A; Witney TH; Andrews LE; Cropper HC; Behera D; Gowrishankar G; Ding Z; Wyss-Coray T; Chin FT; Biswal S; Gambhir SS
    J Neuroinflammation; 2018 Feb; 15(1):55. PubMed ID: 29471880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
    Mao P; Manczak M; Shirendeb UP; Reddy PH
    Biochim Biophys Acta; 2013 Dec; 1832(12):2322-31. PubMed ID: 24055980
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunohistochemical analysis of spinal cord components in mouse model of experimental autoimmune encephalomyelitis.
    Pyka-Fosciak G; Stasiolek M; Litwin JA
    Folia Histochem Cytobiol; 2018; 56(3):151-158. PubMed ID: 30187907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential upregulation of heme oxygenase-1 (HSP32) in glial cells after oxidative stress and in demyelinating disorders.
    Stahnke T; Stadelmann C; Netzler A; Brück W; Richter-Landsberg C
    J Mol Neurosci; 2007; 32(1):25-37. PubMed ID: 17873285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.